{
  "symbol": "KYMR",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["biotechnology sector", "small molecule therapeutics", "speculative retail interest"],
    "riskScore": 7,
    "reason": "Kymera Therapeutics operates in the biotechnology sector, which is prone to hype and speculative interest, especially with its focus on novel therapeutics."
  }
}